Valuation: Navamedic ASA

Market Cap 388M 40.17M 35.1M 32.45M 29.98M 56.45M 3.86B 57.48M 387M 152M 1.89B 151M 148M 6.5B P/E 2026 *
-295x
P/E 2027 * 36.4x
Enterprise Value 508M 52.57M 45.94M 42.47M 39.24M 73.89M 5.05B 75.23M 506M 199M 2.47B 197M 193M 8.51B EV / Sales 2026 *
0.87x
EV / Sales 2027 * 0.74x
Free-Float
30.82%
Yield 2026 *
-
Yield 2027 * -
1 day+2.78%
1 week-1.48%
Current month+1.83%
1 month-2.92%
3 months-15.48%
6 months-23.97%
Current year-30.04%
1 week 16.2
Extreme 16.2
16.95
1 month 15.7
Extreme 15.7
17.55
Current year 15.7
Extreme 15.7
24.5
1 year 15.7
Extreme 15.7
27.9
3 years 15.7
Extreme 15.7
43.9
5 years 15.7
Extreme 15.7
43.9
10 years 8.5
Extreme 8.5
43.9
Manager TitleAgeSince
Chief Executive Officer 60 31/12/2018
Director of Finance/CFO - 31/12/2025
Compliance Officer - -
Director TitleAgeSince
Director/Board Member 54 31/05/2022
Director/Board Member - 31/05/2023
Director/Board Member 60 31/05/2024
Date Insider Type Main position Quantity % Market Cap.
18/12/24Buy

Chief Operating Officer

10,267 0.0581%
08/09/24Fiscal year

Chief Operating Officer

75,000 0.4302%
08/09/24Fiscal year

Chief Executive Officer

80,000 0.4589%
Change 5-day change 1-year change 3-year change Capi.($)
+2.78%-1.48%-26.00%-56.53% 40.17M
-2.48%-6.72%+44.19%+156.43% 1,028B
-1.52%-5.01%+61.87%+58.79% 611B
-1.30%-3.88%+27.81%+79.97% 432B
+0.02%-2.27%+28.35%+22.04% 323B
-0.58%-3.37%+26.65%+43.26% 277B
+0.53%-12.68%+18.46%+21.90% 257B
+0.60%-0.77%-25.96%-40.18% 217B
-1.44%-3.49%+19.60%+56.20% 192B
-1.04%-4.63%+16.01%+68.47% 161B
Average +0.11%-5.04%+19.10%+41.04% 349.84B
Weighted average by Cap. -0.20%-5.52%+33.52%+76.94%

Financials

2026 *2027 *
Net sales 588M 60.78M 53.11M 49.1M 45.36M 85.42M 5.84B 86.97M 586M 230M 2.86B 228M 223M 9.84B 643M 66.52M 58.14M 53.74M 49.65M 93.5M 6.39B 95.2M 641M 251M 3.13B 250M 244M 10.77B
Net income -1.5M -155K -135K -125K -115K -217K -14.85M -221K -1.49M -584K -7.27M -581K -568K -25.03M 10.7M 1.11M 967K 894K 826K 1.55M 106M 1.58M 10.66M 4.18M 52.03M 4.16M 4.06M 179M
Net Debt 120M 12.41M 10.84M 10.02M 9.26M 17.44M 1.19B 17.75M 120M 46.9M 584M 46.6M 45.57M 2.01B 87.4M 9.04M 7.9M 7.3M 6.74M 12.7M 868M 12.93M 87.05M 34.16M 425M 33.94M 33.19M 1.46B
Logo Navamedic ASA
Navamedic ASA is a Norway-based pharmaceutical company. It is a supplier of products delivered to hospitals and pharmacies. Navamedic’s product portfolio consists of prescription and Over The Counter (OTC) pharmaceuticals as well as other healthcare products registered as medical nutrition, medical devices, food supplements or cosmetics. The Company’s offering is divided into four product areas: Consumer Health, Specialty Pharma, Medical Nutrition and Branded Generics. The Company has one business segment which is the Pharma division. Navamedic ASA is present in all Nordic countries, the Baltics and Benelux. The Company has two subsidiaries, Navamedic AB, through which the Company distributes more than 40 products and a Norway-based Novicus Pharma AS.
Employees
38
Date Price Change Volume
15/07/26 NOK 16.65 +2.78% 1,650
14/07/26 NOK 16.20 -1.52% 5,258
13/07/26 NOK 16.45 +0.30% 1,157
10/07/26 NOK 16.40 -1.80% 22,261
09/07/26 NOK 16.70 -1.18% 13,376
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
16.20NOK
Average target price
23.50NOK
Spread / Average Target
+45.06%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. NAVA Stock